MedPath

Post-market study of Pipit-NC Balloon Dilatation Catheter

Not Applicable
Conditions
Health Condition 1: I209- Angina pectoris, unspecified
Registration Number
CTRI/2023/08/056616
Lead Sponsor
Sahajanand Medical Technologies Ltd. (SMT)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient must be at least 18 years of age

2. Patient or a legally authorized representative must provide written informed consent prior to any study related procedure

3. Patient must agree not to participate in any other clinical study during hospitalisation for the index procedure

4. Target lesion(s) can be treated with Pipit-NC PTCA Balloon Dilatation Catheter as per the current IFU.

Exclusion Criteria

Patient not meeting any of the above inclusion criteria

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Device Success <br/ ><br>2. Procedural successTimepoint: Baseline <br/ ><br>(From the start to end of the interventional procedure)
Secondary Outcome Measures
NameTimeMethod
Individual procedural parameters <br/ ><br>- Coronary perforation <br/ ><br>- Coronary dissection <br/ ><br>- Coronary thrombosis <br/ ><br>- Clinically significant arrhythmias (requiring intervention)Timepoint: Up to end of PTCA procedure;Safety endpoints <br/ ><br>- All-cause mortality <br/ ><br>- Any MI <br/ ><br>- Any revascularizationTimepoint: Up to hospital discharge
© Copyright 2025. All Rights Reserved by MedPath